Serum Institute seeks Covishield's booster dose approval from DCGI
India | Dec 01, 2021, 11:56 PM ISTIn an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at Serum Institute of India (SII) cited that the UK's Medicines and Healthcare products Regulatory Agency has already approved the booster dose of AstraZeneca.